SCAI 2026 Building and Sustaining Your RDN Program-Who Benefits Most: Patient Selection for RDN or Medical Therapy, Dr. Kunkel

Who Benefits Most: Patient Selection for RDN or Medical Therapy, Dr. Kunkel

Video Transcription

Video Summary

The speaker explains renal denervation, its main devices, and how patient selection remains difficult because individual responses vary widely. Higher baseline blood pressure seems to predict better response, but no factors reliably identify responders. Patients with diabetes or chronic kidney disease may gain outsized benefit from better blood pressure control, and studies suggest renal denervation is effective and generally safe in these groups. In clinic, patients should be counseled honestly that average results may not apply, benefits may take months, and some people won’t respond. Panelists also recommend remote or home blood pressure monitoring to confirm resistant hypertension.

Asset Caption

closed captions are computer-generated

Keywords

renal denervation

blood pressure control

patient selection

resistant hypertension

home blood pressure monitoring